VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-79043 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Veterinary Active Pharmaceutical Ingredients Manufacturing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET
7.1 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Alivira Animal Health Ltd.
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Excel Industries Ltd.
16.3 Ofichem Group
16.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
16.5 Menadiona
16.6 Afton Pharma
16.7 Jiangsu Lingyun Pharmaceutical Co., Ltd.
16.8 SUANFARMA
16.9 NGL Fine-Chem Ltd.
16.10 FIS - Fabbrica Italiana Sintetici S.p.A
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Service TypeIn House
Contract Outsourcing
   o Contract Development
       Preclinical Development
       Others
   o Contract Manufacturing
       API/Bulk Drugs
       Finished Dose Formulations
By Synthesis Type  
Chemical-based API
Biological API
HPAPI
By Product
Antiparasitic
Anti-infectives
NSAIDs
Vaccines
Biologics
Others
Companies
Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Menadiona
Afton Pharma
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
NGL Fine-Chem Ltd.
FIS - Fabbrica Italiana Sintetici S.p.A
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.